Importantly, it was reported that HIF-1α is highly expressed in Gem-resistant pancreatic cancer cells and this is associated with epithelial-mesenchymal transition of cancer cells [12], suggesting that inhibition of HIF-1α may have potential to overcome the resistance of PDAC cells to the treatment with Gem. This evidence concerns the gene HIF1A and pancreatic neoplasm.